A comprehensive view of DexCom, Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pulp & Paper Industry Market Intelligence Service.
Dexcom and Novo Nordisk urge FDA to back digital health technologies for early detection of prediabetes and undiagnosed Type 2 diabetes; FDA asked for public input last year on tech's role in diabetes detection
Published:
March 04, 2024
by MedTech Dive
|
Tandem Diabetes Care begins widespread US launch of Mobi, its smallest automated insulin delivery system for Type 1 diabetes, compatible with Dexcom's G6 CGM; rollout comes after success in the limited release phase
Published:
February 13, 2024
by FierceBiotech
|
Dexcom launches ONE+ real-time continuous glucose monitoring system in Spain, Belgium and Poland, plans to launch product in Middle East, Africa, other European countries in coming months; global blood glucose monitor market worth about US$5.1B in 2023
Published:
February 06, 2024
by MarketLine
|
Tandem Diabetes Care plans late 2023 launch of slimmed-down X2 insulin pump system; system includes Dexcom G7 continuous glucose monitor sensor and Abbott FreeStyle Libre 2 and 3 integrations
Published:
May 04, 2023
by FierceBiotech
|
Ask us about our Pulp & Paper Industry market view